Clinical Trials Directory

Trials / Completed

CompletedNCT01358994

Metformin Treatment, Renal Function and Lactic Acidosis

Metformin Treatment, Renal Function and Lactic Acidosis. A Population Based

Status
Completed
Phase
Study type
Observational
Enrollment
4,500 (actual)
Sponsor
Skane University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

From a central registry at the National Board of Health and Welfare in Sweden collect all patients in the city of Malmö prescribed metformin during two years. Glomerular filtration rate (eGFR) was estimated from the CKD-EPI formula (n=5408) and compared to a control material (n=2815) from the same town. All cases of severe lactic acidosis rendering ICU admission were also sought. The study hypothesis is that metformin is prescribed to patients with lower GFR than anticipated with very few cases of lactic acidosis registered.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2011-01-01
Completion
2011-04-01
First posted
2011-05-24
Last updated
2018-09-10

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01358994. Inclusion in this directory is not an endorsement.

Metformin Treatment, Renal Function and Lactic Acidosis (NCT01358994) · Clinical Trials Directory